Adam Ang
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
It provides a range of information and resources to support people with down syndrome.
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
This comes after it launched its CDI tool called DxPrime in June.
It claims to help people stop smoking in four weeks.
It is a home-based programme with 10 self-paced modules.
Dozee's sensor-based technology uses AI to track vital parameters.
One of the projects will develop a digital navigator to support people with chronic conditions.
It will be used to accelerate collaborations with pharmaceutical firms.
It will use its latest funds for its global expansion.